These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26645686)

  • 41. A rapid fluorometric assay for the proteolytic activity of SKI-1/S1P based on the surface glycoprotein of the hemorrhagic fever Lassa virus.
    Basak A; Chrétien M; Seidah NG
    FEBS Lett; 2002 Mar; 514(2-3):333-9. PubMed ID: 11943176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GIFT domains: linking eukaryotic intraflagellar transport and glycosylation to bacterial gliding.
    Beatson S; Ponting CP
    Trends Biochem Sci; 2004 Aug; 29(8):396-9. PubMed ID: 15288869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dependence of site-2 protease cleavage of ATF6 on prior site-1 protease digestion is determined by the size of the luminal domain of ATF6.
    Shen J; Prywes R
    J Biol Chem; 2004 Oct; 279(41):43046-51. PubMed ID: 15299016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin/Kexin 9.
    Seidah NG; Abifadel M; Prost S; Boileau C; Prat A
    Pharmacol Rev; 2017 Jan; 69(1):33-52. PubMed ID: 27920219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ADAMTS-4 (aggrecanase-1): N-terminal activation mechanisms.
    Tortorella MD; Arner EC; Hills R; Gormley J; Fok K; Pegg L; Munie G; Malfait AM
    Arch Biochem Biophys; 2005 Dec; 444(1):34-44. PubMed ID: 16289022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The activation and physiological functions of the proprotein convertases.
    Seidah NG; Mayer G; Zaid A; Rousselet E; Nassoury N; Poirier S; Essalmani R; Prat A
    Int J Biochem Cell Biol; 2008; 40(6-7):1111-25. PubMed ID: 18343183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk.
    Bergeron N; Phan BA; Ding Y; Fong A; Krauss RM
    Circulation; 2015 Oct; 132(17):1648-66. PubMed ID: 26503748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Folding pathway mediated by an intramolecular chaperone: the structural and functional characterization of the aqualysin I propeptide.
    Marie-Claire C; Yabuta Y; Suefuji K; Matsuzawa H; Shinde U
    J Mol Biol; 2001 Jan; 305(1):151-65. PubMed ID: 11114254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Engineering the independent folding of the subtilisin BPN' prodomain: analysis of two-state folding versus protein stability.
    Ruvinov S; Wang L; Ruan B; Almog O; Gilliland GL; Eisenstein E; Bryan PN
    Biochemistry; 1997 Aug; 36(34):10414-21. PubMed ID: 9265621
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene set enrichment analysis reveals several globally affected pathways due to SKI-1/S1P inhibition in HepG2 cells.
    De Windt A; Rai M; Bernier L; Thelen K; Soini J; Lefebvre C; Chintawar S; Lavigne J; Saarinen L; Kytömäki L; Munzer JS; Lütjohann D; Pandolfo M; Davignon J; Seidah NG; Laaksonen R
    DNA Cell Biol; 2007 Nov; 26(11):765-72. PubMed ID: 17867930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomic structure and chromosomal mapping of the human site-1 protease (S1P) gene.
    Nakajima T; Iwaki K; Kodama T; Inazawa J; Emi M
    J Hum Genet; 2000; 45(4):212-7. PubMed ID: 10944850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design.
    Musyoka TM; Njuguna JN; Tastan Bishop Ö
    Malar J; 2019 May; 18(1):159. PubMed ID: 31053072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9).
    Schulz R; Schlüter KD; Laufs U
    Basic Res Cardiol; 2015 Mar; 110(2):4. PubMed ID: 25600226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro maturation of Drosophila melanogaster Spätzle protein with refolded Easter reveals a novel cleavage site within the prodomain.
    Ursel C; Fandrich U; Hoffmann A; Sieg T; Ihling C; Stubbs MT
    Biol Chem; 2013 Aug; 394(8):1069-75. PubMed ID: 23729565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hydrogen-deuterium exchange in free and prodomain-complexed subtilisin.
    Sari N; Ruan B; Fisher KE; Alexander PA; Orban J; Bryan PN
    Biochemistry; 2007 Jan; 46(3):652-8. PubMed ID: 17223687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pro region N-terminal domain provides specific interactions required for catalysis of alpha-lytic protease folding.
    Cunningham EL; Mau T; Truhlar SM; Agard DA
    Biochemistry; 2002 Jul; 41(28):8860-7. PubMed ID: 12102628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Site 1 protease is required for proteolytic processing of the glycoproteins of the South American hemorrhagic fever viruses Junin, Machupo, and Guanarito.
    Rojek JM; Lee AM; Nguyen N; Spiropoulou CF; Kunz S
    J Virol; 2008 Jun; 82(12):6045-51. PubMed ID: 18400865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prodomain mutations at the subtilisin interface: correlation of binding energy and the rate of catalyzed folding.
    Wang L; Ruvinov S; Strausberg S; Gallagher DT; Gilliland G; Bryan PN
    Biochemistry; 1995 Nov; 34(47):15415-20. PubMed ID: 7492541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subtilisin kexin isozyme-1 (SKI-1): production, purification, inhibitor design and biochemical applications.
    Mohottalage D; Goto N; Basak A
    Adv Exp Med Biol; 2009; 611():83-4. PubMed ID: 19400104
    [No Abstract]   [Full Text] [Related]  

  • 60. PCSK9 acts as a chaperone for the LDL receptor in the endoplasmic reticulum.
    Strøm TB; Tveten K; Leren TP
    Biochem J; 2014 Jan; 457(1):99-105. PubMed ID: 24144304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.